Loading...
Uploaded by mdandersonorg on Jun 4, 2010
MD Anderson researchers play crucial role in two New England Journal of Medicine studies showing newer drugs for chronic myeloid leukemia work faster and better than imatinib (Gleevec®).
Science & Technology
Standard YouTube License
Load more suggestions
Link to this comment:
All Comments (0)